Market Overview:

The Global Synoptophore Market Was Valued At US$ 236.17 Million In 2022 And Is Expected To Register A Revenue CAGR Of 4.56% To Reach US$ 337.40 Million By 2030.

Synoptophore is a tool used to test binocular vision, measure angles of deviation, and treat binocular aberrations using traditional orthoptic and peptic procedures. It has standard measurements and easy ways to treat problems. A typical Synoptophore is made up of two cylinder tubes with bends in them that are mirror images of each other. The eyepiece of a synoptophore is made up of lenses that magnify perfectly. At the end of the Synoptophore's tube is where picture slides are put into the slide transporter. One of the main things that is driving the growth of the market is the rise in the number of visual acuity disorders like diplopia, amblyopia, strabismus, and others. Synoptophore Market will continue to grow as more people choose non-surgical eye care over surgery.

In the past few years, digital imaging and computer-assisted analysis have been added to synoptophore technology. This makes patient evaluations more accurate and faster. Manufacturers have also made versions of the device that are portable and easy to use to make it easier to get to in remote areas. To make more money, market players have used strategies like expanding distribution networks, running targeted marketing campaigns, and offering full after-sales services. Investing in research and development has also led to synoptophores with better features and more uses. This has brought in more customers and helped the ophthalmology market make more money.

COVID-19 Impact:

During the COVID 19 pandemic, several changes to the protocols have had an effect on medical practices and hospitals. Procedures in ophthalmology that are related to this pandemic have been harmed. Synoptophore is used to find out what's wrong with your eyes, but it doesn't treat any diseases that could kill you. Due to the risk of COVID-19, people are afraid to get their eyes checked and treated, which has an effect on the synoptophore market.

Market Dynamics:

Market Trends:

Another thing that is helping the synoptophore market grow is that people are learning more about how to spot amblyopia and strabismus early on. Amblyopia, which is also called "lazy eye," is a preventable cause of vision loss in children. If it isn't caught and treated early, it can cause permanent vision loss. It can be caused by blurred vision, crossed eyes, or cataracts. Amblyopia from strabismus happens when a child does not get normal vision because his or her eyes are not in the right place. Amblyopia can cause vision loss, so it's important to find out about it and strabismus as soon as possible. People are becoming more aware of how important it is to catch amblyopia and strabismus early. This is expected to help the market grow during the forecast period.

Driving Factors:

• Increasing Incidences of Visual Acuity Disorders

The synoptophore market is growing because there are more people with eye problems like amblyopia, diplopia, and strabismus. The American Academy of Ophthalmology (AAO) says that between 1% and 5% of people in the US live with amblyopia. For example, there are many things that can lead to amblyopia, such as strabismus, premature birth, uncorrected refractive errors, cataracts, traumatic head injuries, and things that are passed down from parents. Also, non-invasive techniques are used to make people more aware of them. So, the growth of the market over the next few years is likely to be driven by the rise of visual acuity disorders.

• The Use of Synoptophore for Binocular Measurements

Binocular vision is the brain's ability to combine two images on the retina into a single visual perception. Its main benefit is 3D vision, and it also gives you a wider field of vision. For many years, the Synoptophore has been the standard instrument for managing orthoptic problems. It is a very reliable way to diagnose and treat problems with how the eyes move. When a retina is irritated by something mechanical or electrical, the feeling is sent to the same spot in space where it would be sent if it were irritated by light at the same retinal point. This instrument gives a full assessment of how well two eyes work together. It makes treatments simple and gives standard measurements. To measure the fusion range, it's best to start with convergence and ask the patient if they see a cat with a tail and ears while slowly turning the arm of the Synoptophore toward them. In the end, ophthalmologists and optometrists need to know how to use the instrument and get used to its value in orthoptic practice. So, it will drive the market for synoptophores.

• The Reliability of Synoptophore Assessment will Drive the Synoptophore Market

Synoptophore is an ophthalmic tool used to diagnose and treat problems with the eye muscles using orthoptic methods. The Synoptophore was the standard ophthalmic tool for a long time. It was used every day by orthoptists. It is the most common and thorough way to test both eyes at the same time. It is used by ophthalmologists to diagnose and treat problems with how the eyes move. Not only ophthalmologists but also optometrists need to know the basics of stereoscopic binocular vision so they can give the right prismatic correction and visual training.

The Synoptophore range of slides can be used to evaluate a wide range of problems with both eyes. The slides help measure nine different ways of looking at something. They also show how depth perception and stereopsis can be measured. Also, it can test for perception, combining of senses, abnormal retinal correspondence, and suppression. When there is a difference in the size of two images, it can be used to tell if aniseikonia is present. Some of its slides are made for people with symptoms of ocular motility who need orthoptic treatment. This instrument can be used for all the standard treatments and measurements, such as checking for cyclophoria, hyperphoria, horizontal, and vertical vergences. The Synoptophore has been THE standard instrument of choice in a busy optometry clinic for many years. It is perfect for diagnosing and treating ocular motility disorders because it can reliably do the most thorough assessment of binocular vision that is currently available.

Restraints/Challenges:

• High Cost of Synoptophore Devices

The growth of the synoptophore market is being held back by the high cost of synoptophore devices. The high cost of synoptophore devices, especially in developing countries, is another big reason why the global synoptophore market isn't growing as fast as it could. It is usually used in ophthalmic diagnostic equipment to test and treat the eyes. Conventional synoptophores have problems like being hard to use by hand, having only one function, and not being interactive. Also, they can't work with automated testing methods. As the device is usually too expensive for most end users to buy, this could slow market growth over the next few years.

• Disadvantages Related to Its Use 

Synoptophore is a common piece of eye diagnostic equipment that is used to test and treat eye function. Existing synoptophore devices have problems, such as only having one function, being hard to use by hand, and not being interactive. Also, it can't work with automated testing methods. To solve these problems, a new type of digital synoptophore has been made.

Synoptophore is ophthalmic diagnostic equipment that is used to test and treat visual function. Most synoptophores are mechanical, like the YZ23 synoptophore made in China by 66 Vision Co., Ltd. It is mostly operated by hand, and there is no way for patients and doctors to talk to each other. What is even more interesting about digital synoptophore is that Changchun optoelectronic device institute made a type of digital synoptophore. It uses sensor technology to send the angle value to the processor through the sensors at different angles. It then uses A/D conversion to show the test results on the LED display screen. But it is still made of mechanical parts, needs to be operated by hand, and the picture library is on cards instead of being fully digitalized. There is no question that, to replace the traditional manual operation, make sure the system is accurate and reliable, and improve how the instruments work together, this system must design an automated motion control algorithm and distribute the feed rate in a smart way while it is running. So, these are the two most important things to look into when looking into digital synoptophore motion control systems.

Opportunities:

• Rising Healthcare Standards in Emerging Nations 

The market for Synoptophore is expected to be driven by better health care in developing countries and more modern health care in developed countries. The Synoptophore market is expected to grow in a big way as the focus of ophthalmic care moves away from surgical procedures and toward non-surgical ones. But the high cost of maintaining the instrument and the fact that people in less-developed countries may not know about noninvasive methods could slow the growth of the Synoptophore market.

• Increasing Technological Advancement

The Synoptophore market is growing because technology is getting better and better at making synoptophore. During the period 2022–2030, the Synoptophore Market is expected to grow because key players are doing more research and development. This leads to new treatments for eye problems, which helps the market grow.

Strategic Development:

• In June 2020 - Haag-Streit announced that it would buy VRmagic, a company based in Germany that makes simulators for training ophthalmologists. With this purchase, Haag-Streit will have everything it needs to offer eye care professionals in the key field of training.
• In May 2021 - Haag-Streit UK said that the Eyestar 900 would come out in the UK. The Eyestar 900 is an OCT-based eye analyzer that uses a swept-source. The swept-source technology makes it possible to get accurate measurements of the whole eye and to measure the topography of the front and back corneal surfaces, the anterior chamber, and the lens.

Key Vendors:

Top market players are

• Haag-Streit UK Ltd.

Haag-Streit UK is a leading provider of diagnostic and surgical equipment for ophthalmologists, optometrists, and orthoptists in the UK. It is based in Harlow, Essex. It designs, makes, and sells a full range of medical devices, such as slit lamps, biometers, perimeters, OCT devices, lasers, medical simulators, and microscopes.

• OCULUS

The company Oculus VR, Inc. works in the software and internet services business. The company's virtual reality gaming systems are all-in-one and don't have any exposed wires. This lets gamers enjoy next-generation entertainment with their current game systems in a convenient way.

• Optikgeräte GmbH

Medical tools are made by OCULUS Optikgeraete GmbH. The company makes optical instruments like binocular loupes, refraction equipment, tonometer, topography, visual test equipment, and other tools. Customers from all over Germany come to OCULUS Optikgeraete.

• TAKAGI SEIKO CO.LTD

In 1990, Takagi Seiko Co.,Ltd. was set up. The Company makes medical, surgical, ophthalmic, and veterinary instruments and equipment as part of its business.

• Metall Zug

A holding company is what Metall Zug AG is. Through its subsidiaries, the company makes appliances, equipment for sterilizing food, wires and cables, and runs resorts. Switzerland is where Metall Zug sells its goods.

• 6 6 VISION-TECH CO., LTD.

6 Over 6 Vision Ltd is a business that makes software. The company builds important optometry tools right into smartphones, so anyone can accurately measure the optical parameters of their glasses for farsighted or nearsighted vision by playing with light. Israel is one of the places that 6 Over 6 Vision serves.

• Gem Optical Instruments Industries

Gem Optical Instruments Industries is known for giving customers what they want. Gem Optical Instruments Industries is a well-known company in the Ophthalmic Lens Meter, Beam Splitters, Ophthalmic Equipment, Ore Microscope, Schiotz Tonometer, and other fields. It is also known for its Motorized Tables, ENT Patient Chair, Tonometer, Lensmeter, Slit Lamp Binocular Microscope, etc.

Segmentation Analysis:

The market is segmented on the basis of type, application, end-user and regions.

By Type Outlook:

In 2019, 56.8% of the market was made up of manual synoptophores. This segment is expected to grow at a healthy rate over the next few years. This is because it is easy to keep up and most synoptophore instruments are available on the market as manual types. Some people in developing countries who care about price still want the manual type of synoptophore.

During the forecast period, automated synoptophore machines are expected to grow at the fastest rate, 4.7% per year. One reason for its rapid growth is that automated synoptophore can do visual acuity tests quickly and accurately by following a standard protocol with little help from an optometrist. Also, the growth of the segment is likely to be helped by the fact that more research activities are being moved to a fully automated and digitalized synoptophore workflow.

• Manual
• Automated

By Application Outlook:

In 2019, 54.7% of all sales came from the segment called "diagnostic." Through simultaneous perception, sensory and motor fusion, and stereopsis tests, synoptophore is often used to find out if there is an imbalance in the muscles that move the eyes. But the growth of the segment has been slowed by the fact that there are other ways to diagnose amblyopia and strabismus, like the photo screen test and the prism cover test, which are less complicated, more patient-friendly, and less expensive. For example, in 2016, the FDA approved a handheld device called Pediatric Vision Scanner (PVS) that could diagnose amblyopia and strabismus with 95% accuracy.

Therapeutic is a new trend that is expected to grow at a CAGR of 4.5% during the period of the forecast. The shift from non-invasive to minimally invasive treatments in ophthalmology has made synoptophore more popular as a way to treat amblyopia. Also, a research paper said that synoptophore can be used as a successful treatment for amblyopia. But patient catering synoptophore for therapeutic purposes has the most concerns about how easy it is to use and how well it works. In these cases, hospitals are making synoptophore that are small enough for patients to use at home out of things like LED lights, synoptophore slides, and binocular toys. So, the market is likely to get small synoptophores for home health care.

• Diagnostic
• Therapeutic

By End-User:

In 2019, 49.7% of the synoptophore market's global revenue came from the hospitals segment. Hospitals are likely to need more synoptophore because more people are going to the emergency room with traumatic brain injuries, strokes, and cerebral palsy. The American Optometric Association says that 32% of people who have had a traumatic brain injury also have convergence insufficiency. In these situations, synoptophore are used for a number of things, such as vision therapy during the active rehabilitation stage and a follow-up visual acuity test after rehabilitation.

Over the next few years, clinics are expected to grow at a CAGR of 4.7%. The segment is growing because people don't have to wait as long, they can get to them more easily, and they cost less than hospitals. This segment is also expected to grow during the forecast period because more and more orthoptists are starting their own practices and the number of people with amblyopia in rural areas is rising.

The other end-user segment includes academic and research centers, walk-in eye care centers, and military camps where eye checks are done. More clinical studies in the field of ophthalmology will use synoptophore, which will help the segment grow. Also, academic centers are becoming more interested in giving their students hands-on experience with advanced synoptophore. This is expected to help the market grow.

• Hospitals
• Clinics
• Others

Regional Insights:

In 2019, 26.4% of the market's revenue came from North America, and that's where it's expected to stay for the next few years as well. It has the largest market share because key market players are involved, the number of people with strabismus and amblyopia is rising, and more people are choosing non-surgical treatment methods. The JCHR says that over 12 million people in the United States alone have amblyopia.

Europe had a big share of the market and is expected to grow at a big rate during the forecast period. The market is expected to grow because more ophthalmic diagnostic devices are being made locally and more people are learning about how advanced technologies can help with eye care.

During the forecast period, the market is expected to grow at a CAGR of 6.0% in Asia-Pacific. The demand for synoptophore in the region is driven by the fact that healthcare standards are getting better in developing economies like India, China, and Japan, and that there are a lot of children living there. The growth of the market in the region is also expected to be helped by the growing infrastructure for ophthalmology care, which is needed to meet the growing demand for health care.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Scope of Report:

Conclusion:

• The report gives a detailed look at the parent market's trends, macroeconomic indicators, and governing factors, as well as each segment's market attractiveness.
• The report also shows how different market factors affect different parts of the market and different places.
• The report looks at how markets are changing at the regional and country level. The scope also includes an overview of the competition, with company market shares and profiles for the top revenue-generating companies.